Related Experiment Videos
Relationships between various uses of antineoplastic drug-interaction terms
G L Wampler1, W H Carter, E D Campbell
1Department of Medicine, Richmond Veterans Administration Medical Center, Virginia 23249.
Cancer Chemotherapy and Pharmacology
|January 11, 1992
Summary
Pharmacologic synergism was not observed for cisplatin and etoposide in leukemia or small-cell lung cancer models. However, clinical data suggest a therapeutic advantage, highlighting the difference between pharmacologic and therapeutic synergy in cancer treatment.
Area of Science:
- Oncology
- Pharmacology
- Cancer Biology
Background:
- The combination of cisplatin and etoposide is used in cancer therapy, particularly for small-cell lung cancer.
- Synergism in drug combinations is often discussed, but its definition and implications can be complex.
- Distinguishing between pharmacologic and therapeutic synergy is crucial for understanding treatment efficacy.
Purpose of the Study:
- To investigate the presence of pharmacologic synergism for the cisplatin and etoposide combination in vitro.
- To compare in vitro findings with observed clinical therapeutic advantages.
- To clarify the concepts of pharmacologic versus therapeutic synergy in antineoplastic drug combinations.
Main Methods:
- In vitro testing of cisplatin and etoposide combination on P388 leukemia cells.
- In vitro testing of the drug combination on four small-cell lung cancer cell lines.
- Analysis of existing clinical data for the combination in various cancers.
Main Results:
- No pharmacologic synergism was detected for cisplatin and etoposide in P388 leukemia cells in vitro.
- Pharmacologic synergism was also absent in the tested small-cell lung cancer cell lines.
- Clinical outcomes suggest a therapeutic advantage for this combination, despite the lack of in vitro pharmacologic synergy.
Conclusions:
- Pharmacologic synergism does not always correlate with observed therapeutic advantages in cancer treatment.
- The definition of synergy can be ambiguous, with pharmacologic and therapeutic meanings differing significantly.
- Drug interaction effects, including synergy, are dose-dependent and cell-line specific, complicating categorical descriptions of antineoplastic drug combinations.